June-July 2009 news about us

Articles that mention MVI

(Click on headline to read the full story.)

Crucell wins funding for malaria vaccine development
July 29, 2009 – Dutch biotechnology firm Crucell (CRCL.AS: Quote, Profile, Research) (CRXL.O: Quote, Profile, Research) said on Wednesday it had gained funding to accelerate the development of a malaria vaccine as it entered into a collaboration with two US-based organisations.
Reuters

Seattle scientists ready to human-test malaria vaccine
July 20, 2009 – Seattle scientists are ready to start human tests of a malaria vaccine that takes an approach pioneered more than 30 years ago but abandoned as wildly impractical.
Seattle Times

Kenya: Malaria Vaccine Trials Launched in High Risk Regions
July 20, 2009 – The third phase trial of the world's most clinically advanced malaria vaccine candidate, known as RTS,S has been carried out in Kenya.
Business Daily (Kenya)

Malaria vaccine researchers face cultural challenges
July 11, 2009 – Scientists running the world's largest malaria vaccine trial are trying to win the support of local communities in sub-Saharan Africa to do their research.
The Lancet

The most important vaccines of our time
June 19, 2009 – Because malaria kills almost 1 million people each year and causes another 250 million to become sick, development of a malaria vaccine is imperative. Most victims are African children.
MSN Health & Fitness

GSK in final trial of vaccine to fight malaria
June 1, 2009 – The world's first malaria vaccine could be available as soon as 2011 after GlaxoSmithKline (GSK) began an advanced trial of its new Mosquirix medicine.
The Times (UK)